BRPI0919857A2 - tratamentos para cancer com radiacao e imunocitocinas - Google Patents

tratamentos para cancer com radiacao e imunocitocinas

Info

Publication number
BRPI0919857A2
BRPI0919857A2 BRPI0919857A BRPI0919857A BRPI0919857A2 BR PI0919857 A2 BRPI0919857 A2 BR PI0919857A2 BR PI0919857 A BRPI0919857 A BR PI0919857A BR PI0919857 A BRPI0919857 A BR PI0919857A BR PI0919857 A2 BRPI0919857 A2 BR PI0919857A2
Authority
BR
Brazil
Prior art keywords
immunocytocin
radiation
cancer treatments
treatments
cancer
Prior art date
Application number
BRPI0919857A
Other languages
English (en)
Portuguese (pt)
Inventor
Karl Josef Kallen
Stephan G Klinz
Sylvia A Holden
Thomas Wickham
Ulrike Gnad-Vogt
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BRPI0919857A2 publication Critical patent/BRPI0919857A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0919857A 2008-10-21 2009-10-21 tratamentos para cancer com radiacao e imunocitocinas BRPI0919857A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10714608P 2008-10-21 2008-10-21
PCT/EP2009/007533 WO2010046097A1 (en) 2008-10-21 2009-10-21 Cancer treatments with radiation and immunocytokines

Publications (1)

Publication Number Publication Date
BRPI0919857A2 true BRPI0919857A2 (pt) 2015-12-15

Family

ID=41510762

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919857A BRPI0919857A2 (pt) 2008-10-21 2009-10-21 tratamentos para cancer com radiacao e imunocitocinas

Country Status (12)

Country Link
US (1) US20100330029A1 (enExample)
EP (1) EP2337579A1 (enExample)
JP (1) JP2012506394A (enExample)
KR (1) KR20110086101A (enExample)
CN (1) CN102196815A (enExample)
AU (1) AU2009306711A1 (enExample)
BR (1) BRPI0919857A2 (enExample)
CA (1) CA2741130A1 (enExample)
EA (1) EA201100626A1 (enExample)
MX (1) MX2011004193A (enExample)
WO (1) WO2010046097A1 (enExample)
ZA (1) ZA201103726B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015124297A1 (en) * 2014-02-19 2015-08-27 Merck Patent Gmbh Cancer-targeted il-12 immunotherapy
BR112019018915A2 (pt) 2017-03-15 2020-04-14 Pandion Therapeutics Inc imunotolerância direcionada
US9861833B1 (en) * 2017-03-30 2018-01-09 Norman H. Anderson Methods of treating melanoma
AU2018273914A1 (en) 2017-05-24 2019-11-14 Pandion Operations, Inc. Targeted immunotolerance
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
USRE50550E1 (en) 2017-12-06 2025-08-26 Pandion Operations, Inc. IL-2 muteins and uses thereof
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
AU2020279240A1 (en) 2019-05-20 2021-12-23 Pandion Operations, Inc. MAdCAM targeted immunotolerance
US11981715B2 (en) 2020-02-21 2024-05-14 Pandion Operations, Inc. Tissue targeted immunotolerance with a CD39 effector
CN112768029B (zh) * 2020-12-27 2023-10-13 上海市东方医院（同济大学附属东方医院） 一种基于单细胞测序的组合用药推荐设备、方法及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110538A1 (en) * 1999-12-28 2002-08-15 Health Research, Inc. Methods and products for tumor immunotherapy using cytokines
CZ2003214A3 (cs) * 2000-06-29 2003-08-13 Merck Patent Gmbh Zesílení odpovědi mediovaných fúzním proteinem protilátka-cytokin kombinovanou léčbou pomocí činidel zvyšujících uptake imunocytokinu
EP1454138B1 (en) * 2001-12-04 2012-01-18 Merck Patent GmbH Immunocytokines with modulated selectivity
US20060263368A1 (en) * 2005-01-10 2006-11-23 Research Development Foundation Targeted chimeric molecules for cancer therapy
SI1966238T1 (sl) * 2005-12-30 2012-08-31 Merck Patent Gmbh Variante interlevkina-12P40 z izboljšano stabilnostjo

Also Published As

Publication number Publication date
KR20110086101A (ko) 2011-07-27
CN102196815A (zh) 2011-09-21
US20100330029A1 (en) 2010-12-30
ZA201103726B (en) 2012-01-25
WO2010046097A1 (en) 2010-04-29
JP2012506394A (ja) 2012-03-15
AU2009306711A1 (en) 2010-04-29
CA2741130A1 (en) 2010-04-29
MX2011004193A (es) 2011-05-24
EP2337579A1 (en) 2011-06-29
EA201100626A1 (ru) 2011-12-30

Similar Documents

Publication Publication Date Title
DE602009000539D1 (de) Strahlentherapiegerät
BRPI0908003A2 (pt) sistemas e métodos para o envio de terapia de radiação
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
PT2340042E (pt) Métodos e composições para o tratamento de cancro
DE602008000456D1 (de) Strahlentherapievorrichtung
BRPI0818320A2 (pt) composição para tratamento de câncer de próstata (pca)
HRP20181385T1 (hr) Ciljanje abcb5 za terapiju raka
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
DE602009001154D1 (de) Strahlentherapievorrichtung und Bestrahlungsverfahren
BR112012004281A2 (pt) uso de metformina tratamento e prevenção de câncer
BR112012011570A2 (pt) aparelho para tratamento de fluido com radiação de microondas
BR112013014316A2 (pt) tratamento de câncer her2-positivo com paclitaxel e trastuzumabe-mcc-dm1
BRPI1008566A2 (pt) métodos e composições para o diagnóstico e tratamento de câncer
DK2361116T3 (da) Bestrålingsindretning
EP2127671A4 (en) THERAPEUTIC CANCER
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
EP2283862A4 (en) CANCER AGENT
BRPI1010874A2 (pt) composição para o tratamento de câncer de próstata
DK2219683T3 (da) Målrettet radioterapi
PT2632452T (pt) Compostos e composições para o tratamento do cancro
BRPI0906444A2 (pt) Compostos de 4-piridinona e seu uso para câncer
BR112012002797A2 (pt) tratamento de câncer de próstata
SMT201700056B (it) Fosfaplatine e relativo utilizzo per il trattamento di cancro
BRPI0922884A2 (pt) compostos para tratamento de câncer
GB0812753D0 (en) Electromagnetic radiation and its therapeutic effect

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.